The constructed diagnostic prediction model and molecular docking analysis demonstrated the potential value of genes such as MMP9, NFKBIA, NFKB1, and SRC in the diagnosis and treatment of MS. This evidence concerns the gene MMP9 and myeloid sarcoma.